Illumina (ILMN) Competitors Jump Higher On Roche Bid (GNOM) (AFFX) (PACB) (more...)
Tweet
Share
E-mailGet Alerts ILMN Hot Sheet
Join SI Premium – FREE
A number of Illumina, Inc. (NASDAQ: ILMN) peers are trading higher after Roche launched a $44.50 hostile takeover bid for Illumina, Inc. (NASDAQ: ILMN). Shares of Illumina are actually trading above the offer on hopes of a higher bid.
Around the sector:
Complete Genomics, Inc. (NASDAQ: GNOM) up 21%
Pacific Biosciences of Californ (NASDAQ: PACB) up 14%
Affymetrix, Inc. (NASDAQ: AFFX) up 7%
Life Technologies Corporation (Nasdaq: LIFE) up 4%
Sequenom, Inc. (Nasdaq: SQNM) up 2%
Qiagen N.V. (Nasdaq: QGEN) up 1%
Luminex Corporation (Nasdaq: LMNX) up 1%
Around the sector:
Complete Genomics, Inc. (NASDAQ: GNOM) up 21%
Pacific Biosciences of Californ (NASDAQ: PACB) up 14%
Affymetrix, Inc. (NASDAQ: AFFX) up 7%
Life Technologies Corporation (Nasdaq: LIFE) up 4%
Sequenom, Inc. (Nasdaq: SQNM) up 2%
Qiagen N.V. (Nasdaq: QGEN) up 1%
Luminex Corporation (Nasdaq: LMNX) up 1%
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nscale targets up to $3B in US IPO as soon as September - Bloomberg
- SEC accuses ex-BofA senior banker Satsky of insider trading - Bloomberg
- Buyout firm Vista explores $3B sale of private markets data provider Allvue - Reuters
Create E-mail Alert Related Categories
Rumors, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
